Benjamin Hickey, EVP, Chief Commercial Officer: Mirati Therapeutics MRTX Sell · Filed 23/12/14

Trade details

Type: Insider sale
Amount: $125,807.4
Shares · price: 2,220 sh · $56.67 a share
Held after: 103,694 sh
Stock: Mirati Therapeutics MRTX
Person: Benjamin HickeyEVP, Chief Commercial Officer
Trade date: 23/12/13
Filed: 23/12/14
Days to filing: 1 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Mirati Therapeutics trades, last 26 weeks

What else happened in Mirati Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/13~24/01/12

Benjamin Hickey's recent trades

Benjamin HickeyPresident, RayzeBio Org
SellBristol Myers Squibb
Sell
Bristol Myers Squibb
BMY
$3,702
97.39 sh
$3,702
Filed 25/05/13
Traded 25/05/09
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$57K
966 sh
$57K
Filed 24/01/18
Traded 24/01/16
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$37.2K
631 sh
$37.2K
Filed 24/01/18
Traded 24/01/16
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$123.1K
2,090 sh
$123.1K
Filed 24/01/09
Traded 24/01/08
Benjamin HickeyEVP, Chief Commercial Officer
SellMirati Therapeutics
Sell
Mirati Therapeutics
MRTX
$40.1K
947 sh
$40.1K
Filed 23/01/19
Traded 23/01/17